blfs_8k.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.  20549
 
______________________________
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
May 14, 2013
Date of report (Date of earliest event reported)
 
____________________________________
 
 
BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware    0-18710 94-3076866
(State or Other Juris-    (Commission File No.) (IRS Employer
diction of Incorporation)             Identification No.)
                                                                                                          
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)
 
(425) 402-1400
(Registrant’s telephone number, including area code)
 
____________________________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
ITEM 2.02.  RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
 
On May 14, 2013, the BioLife Solutions Inc. (the “Company”) issued a press release announcing the financial results of the Company for the first quarter ended March 31, 2013. A copy of the original press release is furnished as Exhibit 99.1 to this current report on Form 8-K.
 
 
ITEM 9.01. EXHIBITS
     
Exhibit #                      Description                                                                
 
  99.1                      Press release dated May 14, 2013.
 
 
 
2
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 14, 2013
 
BIOLIFE SOLUTIONS, INC.
  
       
 
By:
/s/ Daphne Taylor  
    Daphne Taylor  
   
Chief Financial Officer
  
       
 
                
 
3